Dr. Raja Mugasimangalam (Founder and CEO Genotypic technology, Bangalore India) is a former technocrat turned entrepreneur in the Genomics Business. Since 1998, he has been working in close collaboration with Biotech, Pharma, Agriculture / seed companies and academia helping them apply Sequencing, Bioinformatics and Microarray technologies to real life research projects. Genotypic has become the key player in Genomics in India and has led to creation of over 5 start-ups in the areas of molecular diagnostics.
Raja publishes actively in peer reviewed journals and is a reviewer in Journals like PLOSone and BMC Genomics. He is member of the board of studies in many universities for Genomics, Genome informatics and Bioinformatics and of several professional organizations like ABLE, IACR and Indian Biochemists Association. He spends a considerable time delivering seminars and lectures at colleges and universities and is popularizing the Genomics Hub concept for a wider application of Genomics and Informatics.
Prior to founding Genotypic Technology, he worked at Quark Biotech Inc (USA and Israel) developing methods for constructing Microarrays. He received his BSc in Biochemistry from PSG CAS (Coimbatore- 1986), Masters (1998) in Biotechnology from MKU and PhD (1994) in Biotechnology from Madurai Kamaraj University and worked as postdoctoral Scientist at Weizmann Institute of Science (Human Genome Project), Israel and Sidney Kimmel Cancer Center, San Diego USA. Raja worked at Argonne National lab (Chicago USA) on developing novel methods for DNA sequencing for Human Genome Project. At Genotypic, Raja collaborates with leading researchers, scientific institutions and pharma-biotech companies from all over the world. Genotypic is in the process of expanding into all the NGS sequencing technology platforms and applications with the goal of ameliorating the wetlab and analysis process and using them in optimal combination for biological research in various domains
Raja runs the world’s largest Genomics linkedin Group: Genomics NGS and Microarrays with more than 32,000 followers.